Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Sushil K. Srivastava"'
Autor:
Parth S. Roy, Arijit Roy, Pawan K. Joshi, Manish P. Kale, Vijay K. Srivastava, Sushil K. Srivastava, Ravi S. Dwevidi, Chitiz Joshi, Mukunda D. Behera, Prasanth Meiyappan, Yeshu Sharma, Atul K. Jain, Jamuna S. Singh, Yajnaseni Palchowdhuri, Reshma. M. Ramachandran, Bhavani Pinjarla, V. Chakravarthi, Nani Babu, Mahalakshmi S. Gowsalya, Praveen Thiruvengadam, Mrinalni Kotteeswaran, Vishnu Priya, Krishna Murthy V. N. Yelishetty, Sandeep Maithani, Gautam Talukdar, Indranil Mondal, Krishnan S. Rajan, Prasad S. Narendra, Sushmita Biswal, Anusheema Chakraborty, Hitendra Padalia, Manoj Chavan, Satish N. Pardeshi, Swapnil A. Chaudhari, Arur Anand, Anjana Vyas, Mruthyunjaya K. Reddy, M. Ramalingam, R. Manonmani, Pritiranjan Behera, Pulakesh Das, Poonam Tripathi, Shafique Matin, Mohammed L. Khan, Om P. Tripathi, Jyotihman Deka, Prasanna Kumar, Deepak Kushwaha
Publikováno v:
Remote Sensing, Vol 7, Iss 3, Pp 2401-2430 (2015)
India has experienced significant Land-Use and Land-Cover Change (LULCC) over the past few decades. In this context, careful observation and mapping of LULCC using satellite data of high to medium spatial resolution is crucial for understanding the l
Externí odkaz:
https://doaj.org/article/90b4f880c7f74385ac07f1e86af5cc69
Autor:
Carla V. Luciani, Lindsay A. Hobson, Batool Ahmed Omer, Kevin D. Seibert, Sushil K. Srivastava, Matt E. Popkin, John Lepore
Publikováno v:
Journal of Pharmaceutical Innovation. 14:1-14
A series of case histories from IQ consortium member companies will be presented to exemplify how the application of the ICH Q11 vision for enhanced Quality by Design (QbD) development of the active pharmaceutical ingredient (API) can lead to differe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b7d4d6c0bf37c4bd4f9e5ec3ab9ff17
https://doi.org/10.1007/s12247-018-9340-2
https://doi.org/10.1007/s12247-018-9340-2
Autor:
Phil J. Borman, John Lepore, Sushil K. Srivastava, Nathan D. Ide, John Donaubauer, Steven Tymonko, Matt E. Popkin, Lindsay A. Hobson, Kevin D. Seibert, Timothy Curran, Batool Ahmed Omer, Jeffrey M. Kallemeyn, Looker Adam
Publikováno v:
Journal of Pharmaceutical Innovation. 13:367-372
This paper by IQ consortium member companies will describe how the application of the ICH Q11 vision for enhanced QbD development can lead to flexibility through differentiated outcomes for elements of API manufacture, such as the control strategy an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62d076d7d103e30887516e50a28d8f9a
https://doi.org/10.1007/s12247-018-9339-8
https://doi.org/10.1007/s12247-018-9339-8
Publikováno v:
Chemical Engineering in the Pharmaceutical Industry
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8302c0acab5887fd75a51e1996f2fec6
https://doi.org/10.1002/9781119600800.ch50
https://doi.org/10.1002/9781119600800.ch50
Autor:
Nathan R. Domagalski, Sha Lou, Michaël D. B. Fenster, Daniel M. Hallow, Lindsay A. Hobson, Srinivas Tummala, Sushil K. Srivastava, Antonio Ramirez
Publikováno v:
Organic Process Research & Development. 20:1781-1791
This manuscript describes the development of a control strategy for impurities in the final intermediate step of the asunaprevir drug substance utilizing the concepts outlined in the International Conference on Harmonisation guidelines (ICH Q8 (R2),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::202c482c7487c304dc6cfb8e07ed2998
https://doi.org/10.1021/acs.oprd.6b00253
https://doi.org/10.1021/acs.oprd.6b00253
Autor:
Nicholas Murray Thomson, John Lepore, Carla V. Luciani, Sushil K. Srivastava, Erwin Irdam, Robert A. Singer, Kevin D. Seibert, William F. Kiesman, Luke Schenck
Publikováno v:
Organic Process Research & Development. 19:935-948
A series of case histories from IQ consortium member companies are presented in order to exemplify many of the different elements of drug substance control strategies that are required in order to ensure process performance and product quality. Contr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62c9cef8f5be7697fc374b346e5194b4
https://doi.org/10.1021/acs.oprd.5b00146
https://doi.org/10.1021/acs.oprd.5b00146
Autor:
Daniel Wasser, Zhongmin Xu, Robert Wethman, Alan Braem, John M. Wasylyk, Shih-Ying Chang, Fernando Quiroz, David K. Leahy, James S. Bergum, Nathaniel Kopp, Paul C. Lobben, Jale Muslehiddinoglu, Laporte Thomas L, Dimitri Skliar, Evan Barlow, Frank Gibson, Lori Spangler, Chiajen Lai, Sushil K. Srivastava
Publikováno v:
Organic Process Research & Development. 19:900-907
This manuscript describes the control strategy for the commercial process to manufacture brivanib alaninate. The active pharmaceutical ingredient is a prodrug which is susceptible to hydrolysis. In addition to controlling hydrolysis, a robust strateg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80ca7ba371a88f12f41ba7f1fa8ce8fe
https://doi.org/10.1021/op500126u
https://doi.org/10.1021/op500126u
Autor:
Partha Sarathi Roy, Krishna Murthy V. N. Yelishetty, Sushil K. Srivastava, Arijit Roy, Manish Kale, Mohammed Latif Khan, Yeshu Sharma, Shafique Matin, Om Prakash Tripathi, Mruthyunjaya K. Reddy, Mrinalni Kotteeswaran, Nani Babu, Manoj Chavan, Mukunda Dev Behera, Anusheema Chakraborty, Atul K. Jain, Prasanth Meiyappan, V. Chakravarthi, Indranil Mondal, Anjana Vyas, Sandeep Maithani, V. K. Srivastava, Poonam Tripathi, Prasad S. Narendra, J. S. Singh, Reshma M. Ramachandran, R. Manonmani, Pawan Kumar Joshi, M. Ramalingam, Gautam Talukdar, Swapnil A. Chaudhari, Deepak Kushwaha, Pulakesh Das, Praveen Thiruvengadam, Prasanna Kumar, Arur Anand, Jyotihman Deka, Pritiranjan Behera, Bhavani Pinjarla, Ravi S. Dwevidi, Hitendra Padalia, K. S. Rajan, Sushmita Biswal, Yajnaseni Palchowdhuri, Satish N. Pardeshi, Mahalakshmi S. Gowsalya, Vishnu Priya, Chitiz Joshi
Publikováno v:
Remote Sensing; Volume 7; Issue 3; Pages: 2401-2430
Remote Sensing, Vol 7, Iss 3, Pp 2401-2430 (2015)
Remote Sensing, Vol 7, Iss 3, Pp 2401-2430 (2015)
India has experienced significant Land-Use and Land-Cover Change (LULCC) over the past few decades. In this context, careful observation and mapping of LULCC using satellite data of high to medium spatial resolution is crucial for understanding the l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a6f9b93db4bb3ed45e412df9779dcd9
Autor:
Bruce T Lotz, Soojin Kim, San Kiang, Tu Lee, Martha Davidovich, Mario Moises Alvarez, Terence Moore, Faranak Nikfar, Karthi Nagarajan, Sushil K. Srivastava, Kevin P. Girard, Mark Lindrud
Publikováno v:
Scopus-Elsevier
A study of the process−property−performance relationship of a Bristol-Myers Squibb drug substance led to successful development of crystallization and drying processes that produce crystals with desired and consistent physical properties. A contr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ffc90432456a7a1cd1eff73e54e2591
https://doi.org/10.1021/op050091q
https://doi.org/10.1021/op050091q
Process Research and Development for an Efficient Synthesis of the HIV Protease Inhibitor BMS-232632
Autor:
James E. Heikes, Mark D. Schwinden, Mark Lindrud, Michael J. Humora, Fernando Quiroz, David R. Kronenthal, Thomas P. Kissick, Bharat P. Patel, Sushil K. Srivastava, Dau-Ming Hsieh, Lin Dong, Janak Singh, Bin Zheng, Pudipeddi Madhusudhan, Zhongmin Xu, Richard H. Mueller
Publikováno v:
Organic Process Research & Development. 6:323-328
Development of an efficient and scalable process for the human immunodeficiency virus (HIV) protease inhibitor BMS-232632 1-[4-(pyridin-2-yl)phenyl]-5(S)-2,5-bis{[N-(methoxycarbonyl)-l-tert-leucinyl]-amino}-4(S)-hydroxy-6-phenyl-2-azahexane, is descr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50179c1c32a843ef9b7343fecb8439b4
https://doi.org/10.1021/op025504r
https://doi.org/10.1021/op025504r